Mercado mundial de tratamiento de pólipos nasales: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de tratamiento de pólipos nasales

Se espera que el rápido aumento de la población geriátrica, que es más vulnerable al desarrollo de pólipos nasales, y la creciente prevalencia de enfermedades como asma, rinosinusitis crónica, pólipos nasales y rinitis alérgica en todo el mundo, aceleren el crecimiento del mercado en el período de pronóstico. Además, el aumento de las pruebas de detección para el diagnóstico de enfermedades asintomáticas como los pólipos nasales y la creciente conciencia sobre la enfermedad y sus complicaciones allanarán aún más el camino para el crecimiento del mercado. Sin embargo, se prevé que el bajo gasto en atención médica en algunos países limite la tasa de crecimiento del mercado. Además, es probable que las crecientes actividades de investigación y desarrollo y el desarrollo de tratamientos y terapias quirúrgicas mínimamente invasivas creen varias oportunidades nuevas que afectarán el crecimiento de este mercado global de tratamiento de pólipos nasales en el período de pronóstico de 2023 a 2030.

Data Bridge Market Research analiza que el mercado mundial de tratamiento de pólipos nasales, que fue de USD 2.718,74 millones en 2022, se espera que alcance los USD 8.243,69 millones para 2030, y se espera que experimente una CAGR del 5,6% durante el período de pronóstico de 2023 a 2030. El "pólipo etmoidal" domina el segmento de tipo del mercado mundial de tratamiento de pólipos nasales debido a la alta prevalencia de este tipo de pólipos nasales. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de la cartera de proyectos, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de tratamiento de pólipos nasales

Definición de mercado

Los pólipos nasales son crecimientos no cancerosos que se desarrollan en el revestimiento de los conductos nasales o los senos paranasales. Son blandos, indoloros y, por lo general, tienen forma de lágrima o de uva. Los pólipos nasales suelen estar asociados con la inflamación crónica de los tejidos nasales y de los senos paranasales, a menudo como resultado de afecciones como la rinosinusitis crónica, el asma, las alergias o la fibrosis quística. Los pólipos nasales pueden variar en tamaño, desde pequeños y apenas perceptibles hasta crecimientos más grandes que pueden obstruir los conductos nasales y los senos paranasales. Las opciones de tratamiento para los pólipos nasales pueden incluir medicamentos como corticosteroides ( aerosoles nasales u orales), antihistamínicos o antibióticos. En algunos casos, puede ser necesaria la extirpación quirúrgica de los pólipos.

Dinámica del mercado mundial de tratamiento de pólipos nasales

Conductores

• Aumento de la prevalencia del asma, la rinosinusitis crónica, los pólipos nasales y la rinitis alérgica en todo el mundo

Surging prevalence of increasing prevalence of diseases such as asthma, chronic rhinosinusitis, nasal polyps, and allergic rhinitis all around the globe is one of the major factors responsible for fostering growth in the market value. Growing number of different types of diseases, rising awareness about the diseases are all responsible for boosting the market growth rate. 

• Research and Development Proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the pharmaceutical drugs and various diagnosis methods will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the integration of advanced technologies in the healthcare facilities is also bolstering the market growth rate.

• Growing Investment for Healthcare Facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

• Expansion of the Pharmaceutical Industry

The pharmaceuticals industry is experiencing growth due to various factors, including advancements in device development, increasing investments in research and development, and expanding healthcare infrastructure. This growth directly impacts the global nasal polyps treatment market.

• Government Investments on Healthcare Infrastructure

The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Also, high return on investments assured by the research activities will also work in the favor of the market.

Restraints/Challenges

• Rising Competition

The global nasal polyps treatment market is highly competitive, with numerous companies offering a wide range of products. This can make it challenging for new entrants or smaller companies to gain market share and establish a strong presence.

• High Cost associated with Drug Development and Distribution

The cost of drug development and its distribution is very high in the market. Healthcare systems and payers face cost pressures, and there is a growing demand for cost-effective solutions. Manufacturers need to balance the development of innovative implants with affordability to meet market demands.

This global nasal polyps treatment market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global  nasal polyps treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In October 2021, Sanofi announced positive results from a Phase 3 trial evaluating Dupixent (dupilumab) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The trial demonstrated significant reduction in nasal polyp size and improved nasal congestion and sense of smell
• In September 2021, AstraZeneca announced that the European Commission approved Fasenra (benralizumab) as an add-on maintenance treatment for severe eosinophilic nasal polyps in adult patients

Global Nasal Polyps Treatment Market Scope

The global nasal polyps treatment market is segmented on the basis of type, related diseases, treatment, complication, drug class, diagnosis, treatment, medication, route of administration, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Ethmoidal Polyp
• Antrochoanal Polyp
• Others

Related Diseases

• Chronic Sinusitis
• Cystic Fibrosis (CF)
• Allergic Fungal Sinusitis (AFS)
• Others

Treatment

• Pharmacological Therapies
• Surgeries
• Medication
• Others

Complications

• Obstructive Sleep Apnea
• Sinus Infections
• Others

Drug Class

• Corticosteroids
• Antibiotics
• Leukotriene Inhibitors
• Others

Diagnosis

• Nasal Endoscopy
• Blood Test
• Allergy Tests
• Others

Medication

• Nasal Corticosteroids
• Medication to Treat Nasal Polyps
• Chronic Sinusitis
• Others

Route of Administration

• Oral
• Injectable
• Others

End Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• Others

Global Nasal Polyps Treatment Market Regional Analysis/Insights

The global nasal polyps treatment market is analysed and market size insights and trends are provided by country, type, related diseases, treatment, complication, drug class, diagnosis, treatment, medication, route of administration, end user and distribution channel as referenced above.

The countries covered in the global nasal polyps treatment market  report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the global nasal polyps treatment market because of the strong base of healthcare facilities, strong presence of major players in the market, and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth in the global nasal polyps treatment market  during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in healthcare facilities, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global nasal polyps treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global nasal polyps treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global nasal polyps treatment market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Nasal Polyps Treatment Market Share Analysis

El panorama competitivo del mercado global de tratamiento de pólipos nasales proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado global de tratamiento de pólipos nasales.

Algunos de los principales actores que operan en el mercado global de tratamiento de pólipos nasales son:

• Abbott (Estados Unidos)
• Sanofi (Francia)
• AstraZeneca (Reino Unido)
• Industrias farmacéuticas Teva Ltd. (Israel)
• Johnson & Johnson Services, Inc. (Estados Unidos)
• Pfizer Inc. (Estados Unidos)
• Novartis International AG (Suiza)
• GSK plc (Reino Unido)
• Bayer AG (Alemania)
• Industrias farmacéuticas Sun Ltd. (India)
• Cipla Ltd. (India)
• Mylan NV (Estados Unidos)
• Merck KGaA (Alemania)

SKU-50414